Legal and regulatory hot topics: IV therapy and semaglutide

Legal and regulatory hot topics: IV therapy and semaglutide

The fast growth of IV therapy and weight-loss treatments like semaglutide has outpaced many practices' understanding of the legal landscape. In this episode of True to Form, host Audrey Neff sits down with Chase Howard, attorney at the Florida Healthcare Law Firm, to unpack recent legal action involving semaglutide and the top compliance issues practices face when offering IV therapy.

Why Compliance Has Become Urgent

As practices rush to add high-demand services, many underestimate the regulatory complexity involved. Howard explains that recent legal actions against practices offering semaglutide are a warning sign: the rules governing these treatments are real, enforced, and frequently misunderstood. Getting compliance right is not optional; it is essential to protecting the practice from serious legal and financial consequences.

The Semaglutide Landscape

Semaglutide-based weight-loss treatments have exploded in popularity, but the legal basis for how some practices source and offer them has come under scrutiny. Howard walks through the factors behind recent legal action, helping owners understand where practices have gotten into trouble and how to avoid the same pitfalls.

• Sourcing matters. Where and how a practice obtains these medications carries significant legal weight.
• Compounding rules. The regulations around compounded versions are nuanced and frequently misunderstood.
• Marketing claims. How treatments are advertised can create additional legal exposure.

Compliance Issues in IV Therapy

IV therapy presents its own set of compliance challenges, whether a practice is launching a clinic from scratch or adding the service to an existing menu. Howard outlines the key areas owners need to address to operate within the law.

• Scope of practice. Ensuring treatments are administered by appropriately licensed and supervised personnel.
• Medical direction. Establishing proper physician oversight and protocols.
• Corporate structure. Setting up the business in a way that complies with healthcare ownership rules.

Build Compliance In From the Start

Howard's strongest recommendation is to address compliance proactively rather than reactively. Building the right legal and operational foundation when launching a service is far easier and cheaper than untangling problems after they arise. Consulting qualified healthcare counsel early can save a practice from costly mistakes.

Protecting Your Practice

The overarching message is that legal and regulatory diligence is a core part of responsible practice management. As enforcement intensifies and treatments evolve, owners who stay informed and structure their offerings correctly protect their businesses, their licenses, and their patients.

Key Takeaways for Practice Owners

• Take compliance seriously. Enforcement around semaglutide and IV therapy is real and increasing.
• Understand sourcing and compounding rules. These are common sources of legal trouble.
• Address scope, oversight, and structure. IV therapy requires proper licensing and medical direction.
• Consult counsel early. Building compliance in from the start prevents costly problems later.

Howard's legal perspective is a valuable reality check for any practice riding the wave of IV therapy and weight-loss demand: the path to sustainable growth runs through careful, proactive compliance.